You are here

  • Home
  • Archive
  • Volume 20, Issue 3
  • Vitamin K antagonist-experienced patients with a history of stroke/transient ischaemic attack who switched from warfarin to dabigatran increased their rate of recurrent stroke/transient ischaemic attack compared with those on warfarin

Article Text

Article menu
Download PDFPDF
Aetiology/Harm
Cohort study
Vitamin K antagonist-experienced patients with a history of stroke/transient ischaemic attack who switched from warfarin to dabigatran increased their rate of recurrent stroke/transient ischaemic attack compared with those on warfarin

https://doi.org/10.1136/ebmed-2014-110161

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests JWE has received honoraria from Bayer, BI, BMS, Daiichi-Sankyo, Janssen and Pfizer. JB has received honoraria from BMS and Pfizer.

    • Provenance and peer review Commissioned; internally peer reviewed.